Our data demonstrate that reduced circulating LCAT levels predict CKD progression at early stages of renal dysfunction independent of changes in HDL-c levels, supporting the hypothesis that changes in HDL subclass distribution, besides HDL-c levels [6] contribute to the progression of renal damage. This evidence concerns the gene LCAT and chronic kidney disease.